Yüklüyor......
Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
Background. Peroxisome proliferator-activated receptor-α (PPAR-α) is closely associated with the development of cardiac hypertrophy. Previous studies have indicated that bezafibrate (BZA), a PPAR-α agonist, could attenuate insulin resistance and obesity. This study was designed to determine whether...
Kaydedildi:
| Yayımlandı: | PPAR Res |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Hindawi Publishing Corporation
2017
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5239981/ https://ncbi.nlm.nih.gov/pubmed/28127304 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2017/5789714 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|